CONTACT US

Make an initial enquiry to see how we can help you

Please let us know your name.
Invalid Input
Please enter a valid phone number
Please let us know your email address.
Please let us know your message.




News & Insights

Catch up with the latest news.

 

Author :

Over the last few years, there have been multi action claims against companies relating to defective health products.

In 2013, group actions were brought by thousands of women after they were fitted with defective breast implants. 50,000 British women were affected by the faulty French implants which were twice as likely to rupture compared to other implants, causing thousands of women to suffer from health complications.

And in 2016, it was reported that 88 victims were seeking over £1 million in damages over claims that particles of metal from hip implants caused toxic debris to damage nerves and muscles.

More recently, it has been reported that some women are now undergoing hysterectomies in order to remove a sterilisation device that is causing health problems.

Essure is a permanent birth control procedure that works with your body to prevent pregnancy. During the procedure a soft, flexible insert is placed into each fallopian tube. Over the next three months, a barrier forms around the inserts blocking sperm from reaching the eggs so that pregnancy cannot occur.

Some patients are now reporting that they are experiencing adverse effects, including perforation of the uterus and/or fallopian tubes, identification of inserts in the abdominal or pelvic cavity, persistent pain and suspect allergic or hypersensitivity reactions. It has been reported that the insert is made of nickel and polyester (PET) fibres. Once in place, women have said that they are experiencing intense pain, and some patients are suffering from reactions to the nickel and plastic. 

A number of women who have experienced issues after being fitted with the implant say that they were not made aware of the risks. The device has to be removed by surgery and Essure state that this information should be shared with patients considering sterilisation with this procedure during discussion of the benefits and risks of the device.

Essure has been criticised for not considering the long term effects of the implants following clinical trials. The Medicines and Health Products Regulatory Agency (MHRA) have advised that healthcare professionals should be discussing risks prior to any procedure with the patients involved.

It is currently not known how many women have been fitted with the implant, or who have experienced problems following implantation in the UK.

If you would like advice in relation to defective products or a similar matter or any issue, you can contact our specialist solicitors. 

CONTACT US

Please let us know your name.
Invalid Input
Please enter a valid phone number
Please let us know your email address.
Please let us know your message.


  • Ranked in Chambers 2023
  • The Legal 500 - Leading Firm 2023
  •